Clinical Trial Update: Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA. [NA]

View source ↗

Summary

Clinical trial update evaluating tolerance, efficacy and safety of a hydrolyzed infant formula for IgE and non-IgE mediated cow's milk allergy in infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Allergy

Drugs mentioned

• Hydrolyzed Infant Formula (hydrolyzed protein infant formula)

Snippet

Sponsor: United Pharmaceuticals | Conditions: Cow's Milk Allergy | NA | Status: ACTIVE_NOT_RECRUITING